###begin article-title 0
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin p 2
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 637 641 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 687 692 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 687 692 684 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 706 710 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1004 1009 1001 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 1004 1009 1001 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 1098 1099 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1210 1214 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1406 1411 1403 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 1406 1411 1403 1408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 1489 1493 1486 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 986 998 <span type="species:ncbi:9606">participants</span>
###xml 1630 1638 <span type="species:ncbi:9606">patients</span>
Abnormal blood pressure response to exercise is reported to occur in up to a third of hypertrophic cardiomyopathy (HCM) cases and is associated with an increased risk of death, particularly in the young, but it is not known whether the HCM-causing mutation influences blood pressure response to exercise. The purpose of this article is to ascertain whether the blood pressure response to exercise differs among carriers of the R92W mutation in the cardiac troponin T gene (TNNT2), which has been associated with an increased risk of sudden cardiac death in young males; carriers of mutations in the cardiac beta-myosin heavy chain gene (MYH7); and their noncarrier relatives. Thirty R92WTNNT2 carriers, 51 MYH7 mutation carriers, and 68 of their noncarrier relatives were subjected to bicycle ergonometric exercise testing to assess blood pressure response to, as well as heart rate recovery after, exercise. Additional echocardiographic and demographic details were documented for all participants. R92WTNNT2 carriers demonstrated significantly more abnormal blood pressure responses to exercise (P = .021; odds ratio 3.03; confidence interval 1.13-8.12) and smaller increases in systolic blood pressure than MYH7 mutation carriers or related noncarrier control individuals. Although abnormal blood pressure response occurred at similar frequencies in males in all groups (23%-26%), the percentage of R92WTNNT2 females with abnormal blood pressure response was 64%, compared with 25% for MYH7 and 22% for noncarriers. Therefore, these results show that blood pressure response to exercise is influenced by genotype and gender in patients with HCM.
###end p 2
###begin title 3
Keywords
###end title 3
###begin title 4
Abbreviations
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr"><sup>1</sup></xref>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr"><sup>1</sup></xref>
###xml 329 331 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr"><sup>2</sup></xref>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3,4</sup>
###xml 769 772 769 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib4" ref-type="bibr"><sup>3,4</sup></xref>
###xml 793 796 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5,6</sup>
###xml 793 796 793 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6" ref-type="bibr"><sup>5,6</sup></xref>
###xml 1064 1069 1064 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 1081 1082 1081 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1081 1082 1081 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
Hypertrophic cardiomyopathy (HCM), a primary cardiac muscle disease with 0.2% prevalence,1 is characterized primarily by thickening of the ventricular wall in the absence of other hypertrophy-predisposing conditions1 and by an increased risk for sudden cardiac death (SCD), which may relate to changes in cardiac energy and/or Ca2+ homeostasis or histopathological changes in the myocardium.2 HCM is typically caused by mutations in genes encoding protein components of the cardiac sarcomere (), with the three most common causes being mutations in the genes encoding beta cardiac myosin heavy chain (MYH7), cardiac troponin T (TNNT2), and myosin binding protein C. Although the phenotypes resulting from these genetic defects vary greatly, mutations in TNNT2 in humans3,4 and in animal models5,6 have frequently resulted in an increased susceptibility to SCD, often in the presence of mild or absent cardiac hypertrophy. We have previously reported an increased frequency of SCD, affecting young males in particular, in HCM families in which the R92W mutation in TNNT2 segregates,7 although the reason for this poor prognosis was not investigated at the time.
###end p 6
###begin p 7
###xml 256 260 256 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8&#8211;10</sup>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib9 bib10" ref-type="bibr"><sup>8&#8211;10</sup></xref>
###xml 360 364 360 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8,11</sup>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib11" ref-type="bibr"><sup>8,11</sup></xref>
###xml 430 432 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
Blood pressure response to exercise testing is commonly used as an indicator of risk for SCD in patients with HCM. The failure of blood pressure to increase appropriately in response to exercise has been recorded in 8%-33% of ungenotyped patients with HCM.8-10 Abnormal blood pressure responses have been associated with an increase in cardiovascular mortality8,11 and have a reported 15% positive predictive value for SCD in HCM.11 It is not known whether the blood pressure response to exercise in HCM is influenced by genotype.
###end p 7
###begin p 8
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 259 264 259 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 341 345 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 399 401 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 399 401 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
We hypothesized that the R92W mutation, which confers a high rate of SCD, may be associated with an abnormal blood pressure response to exercise. Here we investigated this hypothesis by comparing the blood pressure response to exercise in carriers of the R92WTNNT2 mutation with that of carriers of HCM-causing mutations in the cardiac beta-MYH7 mutations (A797T and R403W) and noncarrier relatives.12
###end p 8
###begin title 9
Methods
###end title 9
###begin title 10
Subjects
###end title 10
###begin p 11
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 262 267 262 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 274 278 274 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 285 289 285 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 290 292 290 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
The study was approved by the Institutional Review Board of the University of Stellenbosch Health Sciences Faculty (N04/03/062). Individuals belonging to consecutively identified HCM families in which either of three founder HCM-causing mutations segregate (R92WTNNT2, A797TMYH7, R403WMYH7)13 who did not have pacemakers, who were in sinus rhythm at the time of the exercise test, and who gave written informed consent were included in this study.
###end p 11
###begin p 12
###xml 163 174 <span type="species:ncbi:9606">participant</span>
A medical and family history was taken, and age, sex, height, and weight as well as sudden death events that had occurred in family members were recorded for each participant. Only sudden deaths occurring in genotyped mutation carriers, or obligate heterozygotes, or individuals with a diagnosis of HCM, or with a history of syncope were considered as SCDs. Blood pressure was taken twice in the sitting position, after 5 minutes of bed rest, and the second measurement was used. Individuals were coded as hypertensive if they on more than one occasion had systolic blood pressure (SBP) >/=140 mmHg or diastolic blood pressure (DBP) >/=90 or were on antihypertensive medication.
###end p 12
###begin title 13
Exercise testing
###end title 13
###begin p 14
###xml 52 55 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 423 435 <span type="species:ncbi:9606">participants</span>
We performed 12-lead electrocardiography (ECG) on a MAC 1200ST machine after 5 minutes of rest in the supine position and from this determined a resting heart rate (HR) and whether normal sinus rhythm was present. All cardioactive medications were discontinued for at least 5 pharmacokinetic half-lives before exercise testing. Exercise testing was performed by practitioners who were blinded to the genotype status of the participants.
###end p 14
###begin p 15
Maximum symptom-limited bicycle ergonometric exercise testing was performed according to the following protocol: eight stages over 24 minutes with incremental increase of 25 W every 2 minutes (25-200 W). Concurrent continuous 12-lead ECG monitoring was performed with the Norav Medical System. SBP and DBP were recorded with a mercury sphygmomanometer by a trained nurse (AG). Blood pressure values were recorded at rest, at 1-minute intervals during exercise, and at 1-minute intervals for 5 minutes during the recovery period.
###end p 15
###begin p 16
###xml 435 437 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 502 504 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
###xml 403 406 <span type="species:ncbi:9606">men</span>
###xml 429 434 <span type="species:ncbi:9606">women</span>
We recorded the maximal workload achieved (in metabolic equivalents [METs]), total exercise time (in minutes and seconds), the maximum SBP and DBP achieved during exercise, the SBP and DBP and HR at peak exercise and at 1-minute intervals during recovery, and the percentage of predicted maximal HR for age and sex achieved by peak exercise. The predicted maximal HR was calculated as 220 minus age for men and 210 minus age for women.14 Chronotropic reserve (CR) was calculated as described elsewhere.15
###end p 16
###begin p 17
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
Normal blood pressure response was defined as an increase of at least 20 mmHg in SBP during exercise, with a gradual decline during recovery.11 Abnormal blood pressure responses were defined as either (1) an initial increase in SBP with a subsequent fall of >20 mmHg compared with the blood pressure value at peak exercise or a continuous decrease in SBP throughout the exercise test of >20 mmHg compared with resting blood pressure (termed hypotensive responses) or (2) an increase of <20 mmHg in SBP from resting state to peak exercise (termed a flat response).
###end p 17
###begin p 18
Exercise was terminated for any of the following reasons: reaching target HR, fatigue, severe dyspnea, significant chest pain, near syncope, or development of arrhythmias.
###end p 18
###begin title 19
Echocardiography
###end title 19
###begin p 20
###xml 384 386 384 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
Echocardiography was performed on all participating individuals, using a standardized procedure, by a single experienced echocardiographer (MR) who was blinded to mutation status. A GE Healthcare Vivid7 cardiovascular ultrasound system was used to determine maximum wall thickness at 16 left ventricular (LV) wall segments on M-mode and two-dimensional images, as described elsewhere.13 Overall maximum LV wall thickness (maxLVWT) was recorded for each individual.
###end p 20
###begin p 21
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 404 406 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
LV mass (LVM) was calculated using the American Society of Echocardiography formula for estimation of LVM from two-dimensional LV linear dimensions as described elsewhere.13 Ejection fraction was determined by the biplane method of discs, using the modified Simpson's rule, while fractional shortening was calculated using LV diastolic and systolic diameters from two-dimensional echocardiography images.16 Stroke volume was calculated as
###end p 21
###begin p 22
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">=</italic>
where LVd = LV end-diastolic diameter and LVs = LV end-systolic diameter. Cardiac output was calculated as CO = (SV x HR)/100, where SV is stroke volume and HR is resting HR.
###end p 22
###begin p 23
###xml 193 195 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sup>
###xml 193 195 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr"><sup>17</sup></xref>
###xml 260 262 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 260 262 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
LV outflow obstruction was considered to be present when a peak instantaneous subaortic gradient >/=30 mmHg was estimated with continuous wave Doppler echocardiography under resting conditions.17 Mitral regurgitation was graded semiquantitatively (1-4+ scale).18
###end p 23
###begin title 24
Statistical analyses
###end title 24
###begin p 25
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 88 93 88 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 205 207 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</sup>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr"><sup>19</sup></xref>
###xml 620 621 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Comparisons were made among three groups consisting of noncarriers, carriers of the R92WTNNT2, and carriers of either of the MYH7 mutations. Quantitative variables were quantile normalized before modeling.19 As the distribution of age, gender, body size, and resting hemodynamic parameters varied between groups, these factors were adjusted for in statistical comparisons of the hemodynamic responses during exercise between groups. General (quantitative) and generalized (dichotomous, categorical) linear mixed-effects models were used, as required, with adjustment for family relatedness as random factor (R package). P <.05 was considered statistically significant.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 11 16 11 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 82 86 82 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 122 126 122 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 443 448 443 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 598 605 594 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 614 618 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 744 748 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 744 748 736 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 813 817 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 830 835 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 830 835 822 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 915 922 907 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 952 957 944 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 952 957 944 949 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 962 966 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
Thirty R92WTNNT2 carriers from seven families, 51 MYH7 mutation carriers (27 A797TMYH7 carriers from 10 families, 24 R403WMYH7 carriers from three families) and 68 of their noncarrier relatives participated in exercise testing. The relevant clinical and demographic characteristics of these individuals are given in Table 1. Total exercise time, workload, and percentage of target HR achieved were similar between groups (Table 2). In the R92WTNNT2 families, SCD had affected predominantly young males (eight males, age at SCD 22.5 +/- 10 years [mean +/- standard deviation]; one female, 62 years; Table 3). Among MYH7 mutation carriers, five male (mean age at SCD 35.8 +/- 17.3 years) and three female (mean age at SCD 32 +/- 20.2 years) A797TMYH7 carriers experienced SCD before the study. At least five of the MYH7 and all R92WTNNT2 SCDs had occurred during periods of physical activity or emotional excitement (Table 3). One SCD in each of the R92WTNNT2 and MYH7 groups occurred in females >40 years.
###end p 27
###begin p 28
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 230 235 230 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 246 253 246 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 475 480 475 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 541 546 541 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 663 667 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 721 728 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl4" ref-type="table">Table 4</xref>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 779 784 779 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 795 803 795 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure 1</xref>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 878 883 878 883 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 897 901 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1045 1050 1045 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 1045 1050 1045 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 1056 1060 1056 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
Whereas abnormal blood pressure response to exercise occurred in about a quarter of control individuals or individuals carrying either MYH7 mutation, this phenomenon was present in significantly more, that is, nearly half, of R92WTNNT2 carriers (Table 2). No individuals demonstrated a continuous decrease in SBP throughout the exercise test. Flat abnormal blood pressure responses predominated in all groups but were the only type of abnormal blood pressure response in R92WTNNT2 carriers (Table 2). Statistical analysis indicated that R92WTNNT2 carriers were 3 times as likely to demonstrate an abnormal blood pressure response to exercise compared with either MYH7 mutation carriers or noncarrier control individuals (Table 4). This was particularly noticeable for female R92WTNNT2 carriers (Figure 1); the percentage of females with abnormal blood pressure response for R92WTNNT2 was 64%, for MYH7 25%, and for noncarriers 22%. In contrast, the percentage of males with abnormal blood pressure response was similar for the three groups (R92WTNNT2 24%; MYH7 23%; noncarriers 26%).
###end p 28
###begin p 29
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 184 189 184 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 291 298 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 343 351 343 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure 2</xref>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
After adjustment for age, sex, resting mean arterial pressure, and resting HR, the effect of exercise on HR and DBP parameters (Table 2) was not different between groups. However, R92WTNNT2 carriers achieved a significantly lower mean SBP at peak exercise, as well as a smaller mean change (Table 2) and a smaller percentage of change in SBP (Figure 2) between resting and peak exercise, than did noncarriers and MYH7 mutation carriers.
###end p 29
###begin p 30
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 153 158 153 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
Interestingly, we also observed that, while the mean rate of SBP change increased in the first 3 minutes of exercise in the control and MYH7 groups, R92WTNNT2 carriers on average demonstrated a slight decrease in the rate at which SBP changed during the first 3 minutes of exercise (Figure 3). However, perhaps owing to the small numbers of individuals involved, this difference was not statistically significant.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 176 180 176 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8,11</sup>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib11" ref-type="bibr"><sup>8,11</sup></xref>
###xml 335 340 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 335 340 335 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 476 480 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Abnormal blood pressure response to exercise has been associated with HCM-related death, with patients <50 years old showing a fourfold increase in premature HCM-related death.8,11 However, it is unknown whether abnormal blood pressure response is influenced by the HCM-causing genotype. Here we show that individuals carrying the R92WTNNT2 mutation are 3 times as likely to experience abnormal blood pressure response upon exercise compared with those carrying either of two MYH7 mutations or noncarrier controls.
###end p 32
###begin p 33
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 173 178 173 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 271 276 271 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 298 305 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 436 441 436 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 507 512 507 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 641 645 641 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 689 693 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 689 693 689 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 771 778 771 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 853 858 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 853 858 853 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 920 925 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 920 925 920 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 931 932 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 931 932 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 997 1001 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 997 1001 997 1001 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>MYH7</italic></sub>
###xml 1082 1089 1082 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 553 556 <span type="species:ncbi:9606">men</span>
We have previously described an increased frequency of SCD, predominantly affecting young males in their teenage years, in two ancestrally related families in which the R92WTNNT2 mutation segregates.7 In this study, we report SCDs in a further two of five additional R92WTNNT2 families identified (Table 3); these families have been shown by genetic haplotype analysis (data not shown) to be ancestrally related to the original two R92WTNNT2 families.7 While SCD had occurred in four (57%) of the seven R92WTNNT2 families, predominantly affecting young men in their teenage years, SCD in MYH7 families was limited to those in which the A797TMYH7 mutation segregates (five [50%] of 10 A797TMYH7 families, 39% of total MYH7 families) and mostly affected adult individuals (Table 3). Similar to our first report of the clinical picture associated with R92WTNNT2 carriers, overt hypertrophy was a rare occurrence in the R92WTNNT2 group7 but occurred more frequently in the MYH7 group (n = 4, all A797TMYH7 carriers), while syncope occurred at comparable levels in both mutation groups (Table 1).
###end p 33
###begin p 34
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 34 39 34 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 137 151 137 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2 tbl4" ref-type="table">Tables 2 and 4</xref>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 219 226 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 269 277 265 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure 2</xref>
###xml 314 318 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 453 458 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
We found that carriers of the R92WTNNT2 mutation demonstrate abnormal blood pressure response to exercise significantly more frequently (Tables 2 and 4; P = .021, odds ratio = 3.03) and show smaller absolute (DeltaSBP, Table 2) and relative (% change from resting SBP, Figure 2) changes in SBP than do carriers of MYH7 mutations or related noncarrier control individuals. Thus, our study of the largest number of cases with an identical mutation in the TNNT2 gene to date provides strong evidence for the influence of genotype on hemodynamic response in HCM.
###end p 34
###begin p 35
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 7 12 7 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 262 267 262 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 291 298 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 300 308 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure 1</xref>
###xml 348 350 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sup>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr"><sup>20</sup></xref>
In R92WTNNT2 carriers, abnormal blood pressure responses were always of the flat type, namely, a failure to increase SBP by >20 mmHg between resting and peak exercise state. This finding, as well as the smaller increases in SBP observed in this study in the R92WTNNT2 group during exercise (Table 2, Figure 1), supports the results of Sakata et al,20 who recently reported that a group consisting of carriers of diverse troponin mutations demonstrated a smaller increase in SBP during exercise than did individuals without troponin mutations.
###end p 35
###begin p 36
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9,21</sup>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib21" ref-type="bibr"><sup>9,21</sup></xref>
###xml 322 327 322 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">22,23</sup>
###xml 322 327 322 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22 bib23" ref-type="bibr"><sup>22,23</sup></xref>
###xml 444 446 444 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sup>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr"><sup>24</sup></xref>
###xml 459 461 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sup>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr"><sup>20</sup></xref>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
The mechanisms underlying abnormal blood pressure response to exercise in HCM are not yet completely understood. While some studies indicate that this response is due to an exaggerated decrease in systemic vascular resistance,9,21 other studies suggest that impaired cardiac output is responsible for exercise hypotension.22,23 Although it remains possible that either or a combination of both mechanisms are at play in subsets of HCM patients,24 Sakata et al20 found that systemic vascular resistance decreased to a similar extent in the TNNT2 and non-TNNT2 groups. They proposed that their findings related to the systolic dysfunction, which would result in decreased cardiac output that developed only in the TNNT2 group during exercise.
###end p 36
###begin p 37
###xml 260 265 260 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25,26</sup>
###xml 260 265 260 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25 bib26" ref-type="bibr"><sup>25,26</sup></xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 499 501 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr"><sup>27</sup></xref>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 536 541 536 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 674 676 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 785 790 785 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23,28</sup>
###xml 785 790 785 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23 bib28" ref-type="bibr"><sup>23,28</sup></xref>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 762 770 <span type="species:ncbi:9606">patients</span>
###xml 821 829 <span type="species:ncbi:9606">patients</span>
The development of abnormal blood pressure response may also be related to autonomic control, as studies of neurotransmitter levels before and after exercise have also previously indicated that HCM patients manifest a sympathoadrenal imbalance during exercise.25,26 The cause of this imbalance is not known, nor is it known whether this imbalance is genotype related, but it has been suggested that the enhanced systolic function that occurs under resting conditions in transgenic mutant TNNT2 mice,27 as well as in prehypertrophic R92WTNNT2 carriers,13 may activate ventricular mechanoreceptors and cause chronic alterations in vagal tone. On the other hand, Kawasaki et al10 recently demonstrated that subendocardial ischemia, which occurs in about 50% of HCM patients upon exercise,23,28 leads to vagal enhancement in patients with HCM, which may be related to the development of abnormal blood pressure response to exercise.
###end p 37
###begin p 38
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 76 81 76 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 296 298 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sup>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr"><sup>29</sup></xref>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 367 372 367 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 594 599 594 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 790 794 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8,11</sup>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib11" ref-type="bibr"><sup>8,11</sup></xref>
###xml 986 988 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sup>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr"><sup>29</sup></xref>
###xml 722 730 <span type="species:ncbi:9606">patients</span>
The preponderance of abnormal blood pressure response in females in the R92WTNNT2 group might be explained by vagal enhancement, which results from either mechanism proposed above, occurring on the background of the normally predominantly parasympathetically biased cardiac regulation in females.29 The preponderance of abnormal blood pressure response in female R92WTNNT2 carriers, who experience less SCD than their male counterparts, could suggest that this hemodynamic factor is not causally associated with the high frequency of sudden death with exercise that we have observed in the R92WTNNT2 group. However, in light of previous longitudinal studies indicating an increase in premature HCM-related death among HCM patients demonstrating abnormal blood pressure response to exercise,8,11 the survival and abnormal blood pressure response data in this study may suggest that a parasympathetic shift is not well tolerated in the predominantly sympathetically regulated male hearts.29
###end p 38
###begin p 39
###xml 127 132 127 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30,31</sup>
###xml 127 132 127 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30 bib31" ref-type="bibr"><sup>30,31</sup></xref>
###xml 277 279 277 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sup>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr"><sup>30</sup></xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 410 415 410 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 515 523 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
Failure to increase SBP appropriately during exercise is indicative of severe coronary artery disease in the general population30,31 and is more marked for those who fail to increase SBP appropriately during the first 3 minutes of exercise rather than later on during exercise.30 This is interesting, given our preliminary observation of the rate of change in SBP, which suggests that individuals with the R92WTNNT2 mutation may fail to increase blood pressure appropriately, particularly early on during exercise (Figure 3).
###end p 39
###begin p 40
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 88 93 88 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 243 246 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8,9</sup>
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib9" ref-type="bibr"><sup>8,9</sup></xref>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 355 360 355 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sup>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr"><sup>30</sup></xref>
###xml 826 828 826 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr"><sup>32</sup></xref>
###xml 1043 1045 1043 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sup>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr"><sup>30</sup></xref>
In contrast to the high rate of abnormal blood pressure response to exercise in the R92WTNNT2 group, the frequency of abnormal blood pressure response to exercise in the MYH7 group was similar to that reported for genotype-unknown HCM patients8,9 and was equal to that observed in the control group of noncarrier relatives (62% from MYH7 and 38% from R92WTNNT2 families). However, the frequency of abnormal blood pressure response to exercise in this control group was much higher than that reported for a non-South African general population (2%-8%).30 The reason for this is not immediately clear; however, half of the control individuals with abnormal blood pressure response in this study were overweight or obese (body mass index >25), perhaps indicating a risk for coronary artery disease and silent myocardial ischemia.32 Other reported causes of an abnormal blood pressure response to exercise include valvular heart disease, orthostatic hypotension, and the use of drugs such as vasodilators, negative inotropic agents, and diuretics.30
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 21 26 21 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 296 301 296 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
Individuals with R92WTNNT2 mutations demonstrate abnormal blood pressure response to exercise significantly more frequently than do individuals with MYH7 mutations or noncarrier controls, indicating that abnormal blood pressure response is influenced by genotype. The preponderance of female R92WTNNT2 carriers with abnormal blood pressure response, with a lower risk of SCD than affected males, supports the suggestion that abnormal blood pressure response may be associated with a parasympathetic shift in the regulation of cardiac function and that parasympathetic shifts are not well tolerated in predominantly sympathetically regulated male hearts. Although implantable defibrillators are the most effective life-saving therapy available for prevention of SCD in HCM, this option is not widely available outside of developed nations owing to cost. Elucidating the molecular mechanisms underlying SCD in HCM may eventually facilitate development of alternative effective therapeutic options.
###end p 42
###begin title 43
Acknowledgment
###end title 43
###begin p 44
The authors thank Peter Doubell for his help in collating the data.
###end p 44
###begin p 45
The first two authors contributed equally to this work.
###end p 45
###begin p 46
This study was funded by a Wellcome Trust International Senior Research Fellowship.
###end p 46
###begin p 47
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro bono</italic>
The Vivid 7 cardiovascular ultrasound system was provided pro bono by GE Healthcare (Germany) for the duration of the study.
###end p 47
###begin p 48
None of the authors have any conflict of interest to disclose.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Prevalence of hypertrophic cardiomyopathy in a general population of young adults
###end article-title 50
###begin article-title 51
Hypertrophic cardiomyopathy
###end article-title 51
###begin article-title 52
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
###end article-title 52
###begin article-title 53
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease
###end article-title 53
###begin article-title 54
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
###end article-title 54
###begin article-title 55
###xml 104 119 <span type="species:ncbi:10090">transgenic mice</span>
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice
###end article-title 55
###begin article-title 56
Sudden death due to troponin T mutations
###end article-title 56
###begin article-title 57
###xml 90 97 <span type="species:ncbi:9606">patient</span>
Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy
###end article-title 57
###begin article-title 58
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy
###end article-title 58
###begin article-title 59
Vagal enhancement due to subendocardial ischemia as a cause of abnormal blood pressure response in hypertrophic cardiomyopathy
###end article-title 59
###begin article-title 60
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy
###end article-title 60
###begin article-title 61
The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events
###end article-title 61
###begin article-title 62
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy
###end article-title 62
###begin article-title 63
Stress testing in screening for cardiovascular disease
###end article-title 63
###begin article-title 64
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Early heart rate recovery after exercise predicts mortality in patients with chronic heart failure
###end article-title 64
###begin article-title 65
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
###end article-title 65
###begin article-title 66
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
###end article-title 66
###begin article-title 67
Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees
###end article-title 67
###begin article-title 68
Heritability of cardiovascular and personality traits in 6,148 Sardinians
###end article-title 68
###begin article-title 69
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes
###end article-title 69
###begin article-title 70
Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy
###end article-title 70
###begin article-title 71
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy
###end article-title 71
###begin article-title 72
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy
###end article-title 72
###begin article-title 73
Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise
###end article-title 73
###begin article-title 74
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Augmented exercise plasma noradrenaline with impaired chronotropic responsiveness in patients with hypertrophic cardiomyopathy
###end article-title 74
###begin article-title 75
Exercise in hypertrophic cardiomyopathy is associated with sympatho-adrenal imbalance
###end article-title 75
###begin article-title 76
###xml 53 68 <span type="species:ncbi:10090">transgenic mice</span>
Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy
###end article-title 76
###begin article-title 77
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy
###end article-title 77
###begin article-title 78
Effect of aging on gender differences in neural control of heart rate
###end article-title 78
###begin article-title 79
Clinical significance of early vs late hypotensive blood pressure response to treadmill exercise
###end article-title 79
###begin article-title 80
Clinical implications of the blood pressure response to exercise
###end article-title 80
###begin article-title 81
Body mass index, metabolic syndrome and carotid atherosclerosis
###end article-title 81
###begin article-title 82
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography
###end article-title 82
###begin p 83
Percentage of males and females within each group demonstrating normal and abnormal blood pressure responses to exercise.
###end p 83
###begin p 84
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Bar graph of adjusted means and 95% confidence interval of untransformed values, showing percentage change in hemodynamic parameters from resting to peak exercise. *P = .029.
###end p 84
###begin p 85
Mean rate of change in SBP in the groups during early exercise and at peak exercise. Values were adjusted for age, sex, body surface area, resting HR, and resting SBP.
###end p 85
###begin p 86
Clinical characteristics of subjects
###end p 86
###begin p 87
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</italic>
###xml 253 255 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr"><sup>33</sup></xref>
Note: Values are given as median (range) for continuous variables and as numbers (percentage) for categorical variables. No individuals were above New York Heart Association (NYHA) class 2 or mitral regurgitation (MR) score 2 (according to Zhogbi et al.33 2003). NA = not applicable.
###end p 87
###begin p 88
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 50 55 50 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
Blood pressure and HR response to exercise in R92WTNNT2 and MYH7 mutation carriers and noncarrier controls
###end p 88
###begin p 89
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Note: Values are given as median (range) for continuous variables and as numbers (percentage) for categorical variables. P-values reflect differences between groups for quantile normalized data, adjusted for age, sex, resting mean arterial pressure, and resting HR. Delta = change in parameter between resting and peak exercise; peak = parameter at peak exercise; % HR achieved = % of predicted maximal HR achieved by peak exercise.
###end p 89
###begin p 90
Characteristics of individuals who experienced SCD
###end p 90
###begin p 91
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</italic>
Note: F = female; M = male.
###end p 91
###begin p 92
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT2</italic>
###xml 83 88 83 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>TNNT2</italic></sub>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
P-values and estimated odds ratio (OR) for abnormal blood pressure response in R92WTNNT2 compared with MYH7 carriers and noncarrier control individuals, adjusted for age, sex, resting mean arterial pressure, resting HR, and family relatedness
###end p 92

